An international team of scientists, led by Nanyang Technological University, Singapore (NTU Singapore), has discovered a new ...

When children living with HIV are injected with neutralizing antibodies, the treatment can suppress cells that contain the virus and are capable of reactivating, an early-stage trial found. Details of ...

An HIV vaccine candidate developed at the Duke Human Vaccine Institute (DHVI) triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a ...

In a recent article posted to the medRxiv* preprint server, scientists explored the coronavirus disease 2019 (COVID-19) BNT162b2 vaccine triggered non-neutralizing and neutralizing antibody functions.

Researchers have developed a novel neutralizing agent, which becomes stronger as the coronavirus mutates. The emergence of unpredictable variants and their stronger infectivity make the COVID-19 ...

Neutralizing antibody levels against the original COVID-19 virus and omicron variants in vaccinated adults tend to decline by at least 15% per month after a single booster shot, a new study using ...

(A) Cryo-EM structure overview of HSV-1 gB in complex with D48 Fab. The side view and top view were presented. The HSV-1 gB trimer and D48 Fab VH/VL were colored differently. (B) Neutralization assay ...

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causal agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, has undergone genomic mutations, which have led to the ...

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of the diverse variants of HIV. Neutralizing antibodies are proteins produced ...